Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Genpact
(NYSE:G)
Intraday
$30.69
-1.07
[-3.37%]
After-Hours
$30.69
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$30.69
-1.07
[-3.37%]
At close: Apr 25
$30.69
0
[0.00%]
After Hours: 4:00PM EDT
Get Report
Watch
Q1 2024 Earnings in 14 days from now on Thu May 9th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Genpact Stock (NYSE:G)
Genpact Stock (NYSE: G)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 22, 2024
Deep Dive Into Genpact Stock: Analyst Perspectives (4 Ratings)
Benzinga Insights
-
3 days ago
Citigroup Maintains Neutral on Genpact, Lowers Price Target to $33
Benzinga Newsdesk
-
3 days ago
Tuesday, March 26, 2024
Even The Chinese EV Powerhouse BYD Had To Slow Down A Bit
Upwallstreet
-
Mar 26, 2024, 1:21PM
Wednesday, March 13, 2024
(G) - Analyzing Genpact's Short Interest
Benzinga Insights
-
Mar 13, 2024, 1:45PM
Tuesday, February 27, 2024
Genpact Announces Five-Year Digital Transformation Engagement With Tropicana Brands Group To Reengineer Global Business Services
Benzinga Newsdesk
-
Feb 27, 2024, 8:18AM
Friday, February 09, 2024
JP Morgan Maintains Underweight on Genpact, Raises Price Target to $43
Benzinga Newsdesk
-
Feb 9, 2024, 3:15PM
Needham Reiterates Buy on Genpact, Maintains $40 Price Target
Benzinga Newsdesk
-
Feb 9, 2024, 7:44AM
Thursday, February 08, 2024
Genpact: Q4 Earnings Insights
Benzinga Insights
-
Feb 8, 2024, 4:20PM
Genpact Sees FY24 Adj. EPS $3.00-$3.03 Vs $3.090 Est.; Revenue $4.57B-$4.61B Vs $4.672B Est.
Benzinga Newsdesk
-
Feb 8, 2024, 4:10PM
Genpact Q4 2023 Adj EPS $0.82 Beats $0.74 Estimate, Sales $1.15B Beat $1.12B Estimate
Benzinga Newsdesk
-
Feb 8, 2024, 4:09PM
Genpact Propels AI-First Strategy With New Executive Leadership Appointments, Vipin Gairola Appointed As Global Operating Officer
Benzinga Newsdesk
-
Feb 8, 2024, 8:23AM
Earnings Scheduled For February 8, 2024
Benzinga Insights
-
Feb 8, 2024, 4:43AM
Tuesday, February 06, 2024
Genpact And ServiceNow Expand Partnership To Offer Source-To-Pay Applications Across Finance And Supply Chain Operations
Benzinga Newsdesk
-
Feb 6, 2024, 9:09AM
Wednesday, January 31, 2024
Genpact Reveals New Multi-year Engagement With Advantage Solutions; Terms Not Disclosed
Benzinga Newsdesk
-
Jan 31, 2024, 5:35PM
Tuesday, January 30, 2024
Key Takeaways From Genpact Analyst Ratings
Benzinga Insights
-
Jan 30, 2024, 11:01AM
Mizuho Initiates Coverage On Genpact with Neutral Rating, Announces Price Target of $40
Benzinga Newsdesk
-
Jan 30, 2024, 6:03AM
Wednesday, January 17, 2024
Citigroup Maintains Neutral on Genpact, Raises Price Target to $36
Benzinga Newsdesk
-
Jan 17, 2024, 10:58AM
Friday, December 15, 2023
Baird Downgrades Genpact to Neutral, Announces $38 Price Target
Benzinga Newsdesk
-
Dec 15, 2023, 6:01AM
Thursday, December 07, 2023
Insider Unloading: Kathryn Stein Sells Options, Realizes $258K
Benzinga Insights
-
Dec 7, 2023, 10:02AM
Rightpoint, A Genpact Company, Earns Epic Games' Unreal Engine Service Partner Status
Benzinga Newsdesk
-
Dec 7, 2023, 8:20AM
Wednesday, November 29, 2023
Genpact Says Working With AWS And Amazon Business To Introduce Transformed Approach To Property Loss Replacement And Claims Management
Benzinga Newsdesk
-
Nov 29, 2023, 5:31PM
Tuesday, November 28, 2023
Genpact Unveils Industry-First Operating Playbook For Scaling Responsible Generative AI Projects
Benzinga Newsdesk
-
Nov 28, 2023, 8:21AM
Thursday, November 09, 2023
Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 9, 2023, 1:13PM
Genpact shares are trading lower after the company reported mixed Q3 financial results and updated guidance.
Benzinga Newsdesk
-
Nov 9, 2023, 11:44AM
Needham Maintains Buy on Genpact, Lowers Price Target to $40
Benzinga Newsdesk
-
Nov 9, 2023, 6:38AM
Wednesday, November 08, 2023
Recap: Genpact Q3 Earnings
Benzinga Insights
-
Nov 8, 2023, 4:10PM
Genpact Announced A Leadership Succession Plan. "Tiger" Tyagarajan, President And CEO, Announces Intention To Retire From The Company; Appointed Balkrishan "Bk" Kalra, , Effective February 9, 2024
Benzinga Newsdesk
-
Nov 8, 2023, 4:07PM
Genpact Updates FY23 EPS Guidance From $2.91-$2.94 To $2.89 Vs $2.92 Est.; Revenue $4.45B Vs $4.6B Est.
Benzinga Newsdesk
-
Nov 8, 2023, 4:05PM
Genpact Q3 EPS $0.76 Beats $0.73 Estimate, Sales $1.14B Miss $1.17B Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 4:04PM
Earnings Scheduled For November 8, 2023
Benzinga Insights
-
Nov 8, 2023, 4:21AM
Thursday, October 05, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
-
Oct 5, 2023, 1:22PM
Thursday, September 28, 2023
Genpact Integrates riskCanvas With Amazon Bedrock
Benzinga Newsdesk
-
Sep 28, 2023, 8:08AM
Tuesday, August 22, 2023
Genpact To Streamline US Leasing And Lending Operations For GE HealthCare With AI-Powered Platform Genpact Cora
Benzinga Newsdesk
-
Aug 22, 2023, 4:31PM
Analyst Expectations for Genpact's Future
Benzinga Insights
-
Aug 22, 2023, 11:00AM
Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
Benzinga Insights
-
Aug 22, 2023, 11:00AM
JP Morgan Downgrades Genpact to Underweight, Announces $40 Price Target
Benzinga Newsdesk
-
Aug 22, 2023, 5:25AM
Friday, August 11, 2023
Volume Reductions Weigh Genpact's Recent Quarters Amid Economic Uncertainty, Analyst Lowers Estimates
Nabaparna Bhattacharya
-
Aug 11, 2023, 3:13PM
Needham Maintains Buy on Genpact, Lowers Price Target to $50
Benzinga Newsdesk
-
Aug 11, 2023, 7:44AM
Thursday, August 10, 2023
JP Morgan Maintains Neutral Rating for Genpact: Here's What You Need To Know
Benzinga Insights
-
Aug 10, 2023, 1:00PM
JP Morgan Maintains Neutral on Genpact, Lowers Price Target to $40
Benzinga Newsdesk
-
Aug 10, 2023, 12:47PM
Genpact shares are trading higher after the company reported better-than-expected Q2 EPS results and announced a partnership with Heubach.
Benzinga Newsdesk
-
Aug 10, 2023, 12:07PM
Alibaba, Illumina, CyberArk Software And Other Big Stocks Moving Higher On Thursday
Lisa Levin
-
Aug 10, 2023, 10:39AM
Wedbush Reiterates Neutral on Genpact, Maintains $45 Price Target
Benzinga Newsdesk
-
Aug 10, 2023, 9:47AM
BMO Capital Maintains Market Perform on Genpact, Lowers Price Target to $41
Benzinga Newsdesk
-
Aug 10, 2023, 9:16AM
Genpact And Heubach Partner To Transform Operations And Accelerate Post-Deal Business Growth
Benzinga Newsdesk
-
Aug 10, 2023, 8:13AM
Wednesday, August 09, 2023
Genpact Limited Sees FY23 EPS $2.91-$2.94 Vs $2.94 Est.; Revenue $4.59B-$4.64B Vs $4.65B Est.
Happy Mohamed
-
Aug 9, 2023, 4:19PM
Genpact Q2 EPS $0.72 Beats $0.69 Estimate, Sales $1.11B Miss $1.12B Estimate
Benzinga Newsdesk
-
Aug 9, 2023, 4:03PM
Genpact Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Lisa Levin
-
Aug 9, 2023, 9:34AM
Earnings Scheduled For August 9, 2023
Benzinga Insights
-
Aug 9, 2023, 4:54AM
Tuesday, August 08, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Aug 8, 2023, 1:32PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch